Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$29.85 - $39.42 $461,809 - $609,866
15,471 New
15,471 $462,000
Q3 2023

Nov 14, 2023

SELL
$13.9 - $23.88 $134,982 - $231,898
-9,711 Reduced 46.09%
11,359 $158,000
Q2 2023

Aug 14, 2023

BUY
$22.4 - $34.92 $471,967 - $735,764
21,070 New
21,070 $484,000
Q3 2022

Nov 14, 2022

BUY
$20.91 - $34.27 $532,786 - $873,199
25,480 New
25,480 $555,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.22B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.